In situ investigation of Fas/FasL expression in chronic hepatitis B infection and related liver diseases.
To evaluate Fas/FasL expression in hepatitis B virus-related chronic liver disease, liver biopsies from 44 such cases were studied immunohistochemically. FasL was detected in the infiltrating lymphocytes and both FasL and Fas were found in the hepatocytes. The Fas and FasL-positive cells were mostly found at the advancing edges of interphase hepatitis, and Fas/FasL expression was closely correlated with the inflammatory activity. Unexpectedly, FasL was also expressed in liver cirrhotic nodules, particularly in those with hepatocellular carcinoma with or without inflammation. These results suggest that the factors which induce hepatocyte transformation might also trigger FasL expression and promote FasL/Fas-mediated apoptosis.
Luo
K X
KX
Nanfang Hospital, Guangzhou, China.
Zhu
Y F
YF
Zhang
L X
LX
He
H T
HT
Wang
X S
XS
Zhang
L
L
D000328:Adult; D053222:Fas Ligand Protein; D005260:Female; D019694:Hepatitis B, Chronic / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D008099:Liver / Q000737:chemistry / Q000166:cytology / Q000821:virology; D008103:Liver Cirrhosis / Q000150:complications / Q000378:metabolism; D008113:Liver Neoplasms / Q000150:complications / Q000378:metabolism; D008297:Male; D008562:Membrane Glycoproteins / Q000096:biosynthesis* / Q000737:chemistry; D008875:Middle Aged; D019014:fas Receptor / Q000096:biosynthesis* / Q000737:chemistry
C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D019014:fas Receptor